Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Type 2 diabetes in Brazil: epidemiology and management.
de Almeida-Pititto B, Dias ML, de Moraes AC, Ferreira SR, Franco DR, Eliaschewitz FG. de Almeida-Pititto B, et al. Among authors: franco dr. Diabetes Metab Syndr Obes. 2015 Jan 5;8:17-28. doi: 10.2147/DMSO.S72542. eCollection 2015. Diabetes Metab Syndr Obes. 2015. PMID: 25609989 Free PMC article. Review.
First Brazilian pancreatic islet transplantation in a patient with type 1 diabetes mellitus.
Eliaschewitz FG, Aita CA, Genzini T, Noronha IL, Lojudice FH, Labriola L, Krogh K, Oliveira EM, Silva IC, Mendonça Z, Franco D, Miranda MP, Noda E, de Castro LA, Andreolli M, Goldberg AC, Sogayar MC. Eliaschewitz FG, et al. Transplant Proc. 2004 May;36(4):1117-8. doi: 10.1016/j.transproceed.2004.04.065. Transplant Proc. 2004. PMID: 15194388 No abstract available.
[Pancreas and islet transplantation in patients with diabetes mellitus].
Sá JR, Gonzalez AM, Melaragno CS, Saitovich D, Franco DR, Rangel EB, Noronha IL, Pestana JO, Bertoluci MC, Linhares M, Miranda MP, Monteagudo P, Genzini T, Eliaschewitz FG. Sá JR, et al. Among authors: franco dr. Arq Bras Endocrinol Metabol. 2008 Mar;52(2):355-66. doi: 10.1590/s0004-27302008000200024. Arq Bras Endocrinol Metabol. 2008. PMID: 18438547 Review. Portuguese.
[Does brittle diabetes exist as a clinical entity?].
Eliaschewitz FG, Franco DR. Eliaschewitz FG, et al. Among authors: franco dr. Arq Bras Endocrinol Metabol. 2009 Jun;53(4):466-9. doi: 10.1590/s0004-27302009000400013. Arq Bras Endocrinol Metabol. 2009. PMID: 19649386 Portuguese.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. Among authors: franco dr. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
46 results